1. $JNJ vs. $PFE vs. $BMY vs. $MRK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=JNJ|PFE|BMY|MRK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  2. Full Lg-Cap Holdings recap: Looking at the long-term http://zen-trends.blogspot.tw/2015/04/lg-cap-portfolio-review-41715.html $SPX $STUDY $AAPL $FB $GS $BMY $UNH $BA $SBUX $DIS

  3. Video coming tomorrow, but here s the watch list for Monday: $TASR $BMY $VGGL $BSPM $CNDO $TROV

  4. Full Lg-Cap Holdings recap: Looking at the long-term http://zen-trends.blogspot.tw/2015/04/lg-cap-portfolio-review-41715.html $SPX $STUDY $AAPL $FB $GS $BMY $UNH $BA $SBUX $DIS

  5. It’s A Big Weekend For Biotech: http://tradingcommonsense.com/?p=2139 $BIIB $PTCT $ISIS $ALNY $MRK $BMY $NVS $JUNO $BLCM $KITE $ZIOP $INCY $INFI $PCYC

  6. $PFE vs. $ACT vs. $MRK vs. $BMY Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=PFE|ACT|MRK|BMY|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  7. $JNJ vs. $BMY vs. $ACT vs. $MRK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=JNJ|BMY|ACT|MRK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  8. Bristol-Myers Squibb Company Stops Opdivo Trial Early http://www.bidnessetc.com/40206-bristolmyers-squibb-company-bmy-stops-opdivo-trial-early/ $BMY

  9. End Of Day Scan: Elder Bar Green $EMC $CSX $BMY $NRF $TLT $SQQQ $HCP $GLD $QID $GBSN

  10. $ACT vs. $TEVA vs. $ABBV vs. $BMY Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ACT|TEVA|ABBV|BMY|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  11. latest trades $BSPM $BMY $ROSG $KITE $GBSN http://www.upstockstrading.com/2015/04/upstocks-daily-newsletter-bspm-npd-cndo-cgix-rei-vslr-visn-dvax-ifon-gbsn%e2%80%8f/

  12. $ABBV vs. $BMY vs. $LLY vs. $TEVA Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ABBV|BMY|LLY|TEVA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  13. RT @23aloha: Biotech Tweets of the Week http://www.biotechduediligence.com/tweets2015-04-13.html $GWPH $SAGE $ADXS $ADRO $BLUE $GLPG $SSH $MNTA $BMY $CLVS $IBB $XBI

  14. Biotech Tweets of the Week c/o @23aloha http://www.biotechduediligence.com/blog $GWPH $SAGE $ADXS $ADRO $ATHX $BLUE $GLPG $SSH $MNTA $BMY $CLVS $IBB $XBI

  15. @GottesFundLP: $BMY Hanging tuff in red sea s.

  16. $BMY Hanging tuff in red sea s.

  17. Best I can tell from patent/lit searches Lexicon s new clinical candidate for neuropathic pain is probably an AAK1 inhibitor $LXRX $BMY

  18. Why Bristol-Myers Squibb ending a drug trial early is a good thing $BMY http://www.benzinga.com/general/biotech/15/04/5418929/why-bristol-myers-squibb-ending-a-drug-trial-early-is-a-good-thing

  19. $BMY Latest News update Bristol-Myers Squibb Co (NYSE:BMY): http://www.wsnews4investors.com/news-updates-by-Bristol-Myers-Squibb/

  20. $ADRO opportunity to get in prior to the #AACR15 conference next week when more will be buying --do your own DD- $ADXS $BMY $MRK $NVS

  21. Next week #AACR15 American Association of #Cancer #Research in focus #Investing #Immuno-oncology $ADRO $ADXS $MRK $NVS $BMY

  22. $ACT vs. $MRK vs. $BMY Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ACT|MRK|BMY|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  23. Bristol s Opdivo Scores Again Against Lung Cancer http://news.investors.com/technology/041715-748329-bmy-stock-up-as-opdivo-lung-cancer-trial-halted.htm #IBDNews via @IBDinvestors $BMY $SNY $MRK

  24. Gainers Today $NFLX $STX $TROV $BMY IGTE $RCPT $SM $SUM $OF $GSH $MAT $GLD $VXX $UVXY

  25. With Bristol-Myers trial stopped early, what s next? $BMY http://benzinga.com/z/5418415